Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis / Anna Laurén, Manuela Braun, Chiara Cazzin, Kelly Colleti, Chris Cox, Lisa Dietz, Thomas Emrich, Kristin Geddes, Kate Herr, Tracy Iles, Alexandra Rogue, Yvan Verlinden, Philip Timmerman
In this manuscript, the European Bioanalysis Forum reports back on their discussions on practical and scientific considerations related to bioanalytical applications of quantitative polymerase chain reaction. This publication follows an earlier publication in which the European Bioanalysis Forum recommends to consider principles of context of use when defining assay acceptance criteria for method validation criteria and sample analysis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
Erscheinungsort nicht ermittelbar: 2022 |
| Enthalten in: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Laurén, Anna [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Themen: |
Assay development |
|---|
| Umfang: |
1 Online-Ressource (9 p) |
|---|
| doi: |
10.4155/bio-2022-0170 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
KFL011092890 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL011092890 | ||
| 003 | DE-627 | ||
| 005 | 20230713210630.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230609s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/bio-2022-0170 |2 doi | |
| 035 | |a (DE-627)KFL011092890 | ||
| 035 | |a (KFL)prod_FICIBQ_10.4155/bio-2022-0170 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Laurén, Anna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis |c Anna Laurén, Manuela Braun, Chiara Cazzin, Kelly Colleti, Chris Cox, Lisa Dietz, Thomas Emrich, Kristin Geddes, Kate Herr, Tracy Iles, Alexandra Rogue, Yvan Verlinden, Philip Timmerman |
| 264 | 1 | |a [Erscheinungsort nicht ermittelbar] |c 2022 | |
| 300 | |a 1 Online-Ressource (9 p) | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a In this manuscript, the European Bioanalysis Forum reports back on their discussions on practical and scientific considerations related to bioanalytical applications of quantitative polymerase chain reaction. This publication follows an earlier publication in which the European Bioanalysis Forum recommends to consider principles of context of use when defining assay acceptance criteria for method validation criteria and sample analysis | ||
| 653 | |a assay development | ||
| 653 | |a assay validation | ||
| 653 | |a biomarker | ||
| 653 | |a context of use | ||
| 653 | |a quantitative polymerase chain reaction | ||
| 653 | |a regulated bioanalysis | ||
| 700 | 1 | |a Braun, Manuela |e verfasserin |4 aut | |
| 700 | 1 | |a Cazzin, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Colleti, Kelly |e verfasserin |4 aut | |
| 700 | 1 | |a Cox, Chris |e verfasserin |4 aut | |
| 700 | 1 | |a Dietz, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Emrich, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Geddes, Kristin |e verfasserin |4 aut | |
| 700 | 1 | |a Herr, Kate |e verfasserin |4 aut | |
| 700 | 1 | |a Iles, Tracy |e verfasserin |4 aut | |
| 700 | 1 | |a Rogue, Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Verlinden, Yvan |e verfasserin |4 aut | |
| 700 | 1 | |a Timmerman, Philip |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioanalysis |d London : Future Science, 2009 |h Online-Ressource |w (DE-627)KFL000038172 |w (DE-600)2571813-7 |w (DE-576)398101434 |x 1757-6199 |7 nnns |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/future-medicine-ejournals-pharmazie/doi.org/10.4155/bio-2022-0170 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 935 | |i IMPORT_0628_prod_FICIBQ_03 | ||
| 951 | |a AR | ||